GSA Capital Partners’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-17,236
| Closed | -$250K | – | 1679 |
|
|
2022
Q3 | $250K | Sell |
17,236
-21,414
| -55% | -$311K | 0.03% | 1055 |
|
|
2022
Q2 | $380K | Buy |
38,650
+15,148
| +64% | +$149K | 0.06% | 673 |
|
|
2022
Q1 | $346K | Buy |
23,502
+12,003
| +104% | +$177K | 0.05% | 798 |
|
|
2021
Q4 | $152K | Buy |
+11,499
| New | +$152K | 0.02% | 1269 |
|
|
2021
Q1 | – | Sell |
-22,664
| Closed | -$430K | – | 1290 |
|
|
2020
Q4 | $430K | Sell |
22,664
-2,802
| -11% | -$53.2K | 0.07% | 517 |
|
|
2020
Q3 | $321K | Buy |
+25,466
| New | +$321K | 0.05% | 684 |
|
|
2020
Q2 | – | Sell |
-16,786
| Closed | -$128K | – | 867 |
|
|
2020
Q1 | $128K | Sell |
16,786
-50
| -0.3% | -$381 | 0.03% | 859 |
|
|
2019
Q4 | $300K | Buy |
16,836
+6,515
| +63% | +$116K | 0.03% | 1029 |
|
|
2019
Q3 | $120K | Buy |
+10,321
| New | +$120K | 0.02% | 1258 |
|
|
2019
Q2 | – | Sell |
-7,371
| Closed | -$211K | – | 1582 |
|
|
2019
Q1 | $211K | Buy |
+7,371
| New | +$211K | 0.02% | 1214 |
|